Diane P. Wood

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

Martin Dennis, Gillian Mead, John Forbes et al. · The Lancet · 2018 · 286 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)

Julie Bernhardt, Leonid Churilov, Fiona Ellery et al. · Neurology · 2016 · 217 citations · Full text

Medicine, Rehabilitation Medicine, Geriatric Rehabilitation +14

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock et al. · The Lancet · 2019 · 195 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

Philip M. Bath, Polly Scutt, Jason P. Appleton et al. · The Lancet · 2019 · 194 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton et al. · The Lancet · 2017 · 180 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17